Chargement en cours...
Modulation of Sodium Iodide Symporter in Thyroid Cancer
Radioactive iodine (RAI) is a key therapeutic modality for thyroid cancer. Loss of RAI uptake in thyroid cancer inversely correlates with patient’s survival. In this review, we focus on the challenges encountered in delivering sufficient doses of I-131 to eradicate metastatic lesions without increas...
Enregistré dans:
| Publié dans: | Horm Cancer |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer US
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4458071/ https://ncbi.nlm.nih.gov/pubmed/25234361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12672-014-0203-0 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|